GENETIC APPROACHES TO THE TREATMENT OF THE B-THALASSEMIA: A) ENGINEERED EKLF FACTORS B) RECOGNITION SITE PROBE CLONING OF NOVEL g-GLOBIN BINDING FACTORS
- 2 Anni 1999/2001
- 82.633€ Totale Fondi
Descrizione non disponibile
Pubblicazioni Scientifiche
- 2002 BLOOD CELLS MOLECULES AND DISEASES
Cloning MafF by recognition site screening with the NFE2 tandem repeat of HS2: Analysis of its role in globin and GCSI genes regulation
- 2002 JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
A novel splicing defect (IVS6+1G > T) in a patient with pseudovitamin D deficiency rickets
